NCT03489018View on ClinicalTrials.gov

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

2,100

Participants

Timeline

Start Date

March 21, 2019

Primary Completion Date

September 30, 2022

Study Completion Date

November 1, 2024

Conditions
Pneumococcal InfectionStreptococcus Pneumoniae InfectionInvasive Pneumococcal Disease, Protection Against
Interventions
BIOLOGICAL

PCV10

Experimental arms will receive a lower dose of the intervention than the marketed dose.

BIOLOGICAL

PCV13

Experimental arms will receive a lower dose of the intervention than the marketed dose.

Trial Locations (1)

Unknown

KEMRI Wellcome Trust Research Programme, Kilifi

All Listed Sponsors
collaborator

University College, London

OTHER

collaborator

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

National Institute of Health Research (NIHR) Mucosal Pathogens Research Unit (MPRU)

UNKNOWN

collaborator

Wellcome Trust

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03489018 - The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants | Biotech Hunter | Biotech Hunter